Litigation

Recent Posts

Johnson & Johnson, 2 Units Plead Guilty, Pay $2.2 Billion In Criminal, Civil Penalties
Posted on 4 Nov 2013 by Tom Moylan

WASHINGTON, D.C. — (Mealey’s) Two Johnson & Johnson subsidiaries have pleaded guilty, and the parent company and two subsidiaries will pay $2.2 billion in criminal fines, civil penalties and forfeitures in one criminal and several civil... Read More

Tags: drugs , Medicare , off-label marketing , Risperdal , Natrecor , Medicaid , Litigation , Invega , United States of America v. Janssen Pharmaceuticals , Janssen Pharmaceuticals Inc. , Scios Inc. , diabetes , Johnson & Johnson , antipsychotic drug , U.S. Justice Department